Does IRINOTECAN Cause Malignant neoplasm progression? 1,007 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,007 reports of Malignant neoplasm progression have been filed in association with IRINOTECAN (Irinotecan Hydrochloride). This represents 3.6% of all adverse event reports for IRINOTECAN.
1,007
Reports of Malignant neoplasm progression with IRINOTECAN
3.6%
of all IRINOTECAN reports
364
Deaths
167
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IRINOTECAN?
Of the 1,007 reports, 364 (36.1%) resulted in death, 167 (16.6%) required hospitalization, and 16 (1.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRINOTECAN. However, 1,007 reports have been filed with the FAERS database.
What Other Side Effects Does IRINOTECAN Cause?
Diarrhoea (4,157)
Neutropenia (2,533)
Nausea (2,374)
Disease progression (2,018)
Off label use (2,018)
Vomiting (1,944)
Fatigue (1,515)
Febrile neutropenia (1,357)
Anaemia (1,231)
Thrombocytopenia (1,214)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IRINOTECAN Alternatives Have Lower Malignant neoplasm progression Risk?
IRINOTECAN vs IRON
IRINOTECAN vs IRON DEXTRAN
IRINOTECAN vs IRON ISOMALTOSIDE 1000
IRINOTECAN vs IRON POLYMALTOSE
IRINOTECAN vs IRON SUCROSE